Noveome Biotherapeutics, Inc. Publishes Data Demonstrating Anti-Inflammatory Activity of ST266 in a Preclinical Model of Optic Neuritis
PITTSBURGH--(BUSINESS WIRE)--#ST266--Noveome announces publication of data demonstrating anti-inflammatory activity of ST266 in a preclinical model of optic neuritis, the most common presenting sign of multiple sclerosis.